Literature DB >> 7780639

Functional effects of long-term activation on human beta 2- and beta 3-adrenoceptor signalling.

F Nantel1, M Bouvier, A D Strosberg, S Marullo.   

Abstract

The functional effects of long-term activation of beta-adrenoceptors were investigated by measuring adenylyl cyclase activity, cyclic AMP accumulation and cyclic AMP-dependent protein kinase activity in CHW and L cells expressing either human beta 2- or beta 3-adrenoceptors. Pre-incubation of CHW and L cells expressing beta 2-adrenoceptors with 10 microM isoprenaline for 24 h produced a marked reduction in the total receptor number and dramatically reduced the capacity of the receptor to stimulate adenylyl cyclase maximally. In contrast, the ability of beta 3-adrenoceptors number was observed in L but not in CHW cells. Maximal levels of intracellular cyclic AMP concentrations were reached during the first hour of receptor activation with isoprenaline in all four cell lines. In the absence of phosphodiesterase inhibitors, cyclic AMP decreased to basal levels within 24 h of continuous stimulation. This phenomenon occurred more rapidly in cells expressing the beta 2- than the beta 3-adrenoceptors. These results confirm that, at the level of adenylyl cyclase stimulation and cyclic AMP accumulation, the beta 3-adrenoceptor is more resistant than the beta 2-adrenoceptor to long-term desensitization. However, when cyclic AMP-dependent protein kinase activity was considered, a 24 h stimulation of beta 2- and when cyclic AMP-dependent protein kinase activity was considered, a 24 h stimulation of beta 2- and beta 3-adrenoceptor expressing cells led to the desensitization of the kinase in L but not in CHW cells. In conclusion, long-term desensitization may have distinct functional effects on cell signalling depending on the receptor subtype and the cell type considered. These findings might have practical implications for future strategies involving long-term therapies with receptor agonists.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780639      PMCID: PMC1510334          DOI: 10.1111/j.1476-5381.1995.tb13311.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Regulation of intracellular cyclic AMP concentrations in hepatocytes involves the integrated activation and desensitization of adenylyl cyclase coupled with the action and activation of specific isoforms of cyclic AMP phosphodiesterase.

Authors:  M D Houslay; S L Griffiths; Y M Horton; C Livingstone; M Lobban; F Macdonald; N Morris; J Pryde; G Scotland; Y Shakur
Journal:  Biochem Soc Trans       Date:  1992-02       Impact factor: 5.407

2.  Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.

Authors:  B J O'Connor; S L Aikman; P J Barnes
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

Review 3.  Autoantibodies to the TSH receptor in patients with autoimmune thyroid disease.

Authors:  A M McGregor
Journal:  Clin Endocrinol (Oxf)       Date:  1990-12       Impact factor: 3.478

4.  Psychological aspects of dietary weight loss and medication with the atypical beta agonist BRL 26830A in obese subjects.

Authors:  M MacLachlan; A A Connacher; R T Jung
Journal:  Int J Obes       Date:  1991-01

5.  Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides.

Authors:  G G Cadd; M D Uhler; G S McKnight
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

6.  Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors.

Authors:  M J Lohse; J L Benovic; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

7.  Evaluation of kemptide, a synthetic serine-containing heptapeptide, as a phosphate acceptor for the estimation of cyclic AMP-dependent protein kinase activity in respiratory tissues.

Authors:  M A Giembycz; J Diamond
Journal:  Biochem Pharmacol       Date:  1990-01-15       Impact factor: 5.858

8.  Positively cooperative cAMP phosphodiesterase attenuates cellular cAMP responses.

Authors:  R Barber; T J Goka; R W Butcher
Journal:  Second Messengers Phosphoproteins       Date:  1992

9.  Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements.

Authors:  R F Thomas; B D Holt; D A Schwinn; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

10.  Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to adenylyl cyclase in isolated adipocytes.

Authors:  J G Granneman
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

View more
  9 in total

Review 1.  Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?

Authors:  Katerina Okeke; Stephane Angers; Michel Bouvier; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 2.  Upregulation of β3-adrenoceptors-a general marker of and protective mechanism against hypoxia?

Authors:  Massimo Dal Monte; Bronwyn A Evans; Ebru Arioglu-Inan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-18       Impact factor: 3.000

3.  Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.

Authors:  M Bardou; C Loustalot; J Cortijo; B Simon; E Naline; M Dumas; S Esteve; T Croci; P Chalon; R Frydman; P Sagot; L Manara; E J Morcillo; C Advenier
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-10       Impact factor: 3.000

5.  (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.

Authors:  C Rouget; M Breuiller-Fouché; F J Mercier; M J Leroy; C Loustalot; E Naline; R Frydman; T Croci; E J Morcillo; C Advenier; M Bardou
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

7.  Agonist-induced desensitization of human β3-adrenoceptors expressed in human embryonic kidney cells.

Authors:  Martina B Michel-Reher; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-12       Impact factor: 3.000

Review 8.  The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues.

Authors:  Lauriane Y M Michel; Charlotte Farah; Jean-Luc Balligand
Journal:  Cells       Date:  2020-12-02       Impact factor: 6.600

Review 9.  Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?

Authors:  Marc Bardou; Céline Rouget; Michèle Breuiller-Fouché; Catherine Loustalot; Emmanuel Naline; Paul Sagot; René Frydman; Esteban J Morcillo; Charles Advenier; Marie-Josèphe Leroy; John J Morrison
Journal:  BMC Pregnancy Childbirth       Date:  2007-06-01       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.